CCL2 and head and neck squamous cell carcinoma: In breast cancer, the concentration of MCP-1 in tissue extracts has been similarly reported as an indicator of early relapse, further supporting the possibility of using histological MCP-1 to determine the aggressiveness of HNSCC [42].